Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-11-08
DOI
10.3389/fonc.2019.01182
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Optimizing oncolytic virotherapy in cancer treatment
- (2019) Kevin Harrington et al. NATURE REVIEWS DRUG DISCOVERY
- Advances in oncolytic adenovirus therapy for pancreatic cancer
- (2018) Callum Baird Nattress et al. CANCER LETTERS
- Double-Dose Adenovirus-Mediated Adjuvant Gene Therapy Improves Liver Transplantation Outcomes in Patients with Advanced Hepatocellular Carcinoma
- (2018) Ruidong Zhu et al. HUMAN GENE THERAPY
- Adenovirus Coding for Interleukin-2 and Tumor Necrosis Factor Alpha Replaces Lymphodepleting Chemotherapy in Adoptive T Cell Therapy
- (2018) João Manuel Santos et al. MOLECULAR THERAPY
- Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer
- (2018) Giulia Marelli et al. Frontiers in Immunology
- Designer Oncolytic Adenovirus: Coming of Age
- (2018) Alexander Baker et al. Cancers
- Adenovirus armed with VGLL4 selectively kills hepatocellular carcinoma with G2/M phase arrest and apoptosis promotion
- (2018) Wenjie Xie et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX
- (2018) Aleksei A. Stepanenko et al. VIRUS RESEARCH
- Oncolytic adenovirus: A tool for cancer therapy in combination with other therapeutic approaches
- (2018) Nasser Hashemi Goradel et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Systemic virotherapy for multiple myeloma
- (2017) Stefania Oliva et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Virotherapy Research in Germany: From Engineering to Translation
- (2017) Guy Ungerechts et al. HUMAN GENE THERAPY
- Surface expression of anti-CD3scfv stimulates locoregional immunotherapy against hepatocellular carcinoma depending on the E1A-engineered human umbilical cord mesenchymal stem cells
- (2017) Qing Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo
- (2017) Xiaoni Liu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma
- (2017) Hiroaki Sawahara et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Genetically engineered recombinant adenovirus expressing interleukin‑2 for hepatocellular carcinoma therapy
- (2017) Yunpeng Sun et al. Molecular Medicine Reports
- Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma
- (2017) Wojciech K. Panek et al. Oncotarget
- 11R-P53 and GM-CSF Expressing Oncolytic Adenovirus Target Cancer Stem Cells with Enhanced Synergistic Activity
- (2017) Sai-qun Lv et al. Journal of Cancer
- VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer
- (2017) Yinglong Zhang et al. Scientific Reports
- Oncolytic Adenovirus Complexes Coated with Lipids and Calcium Phosphate for Cancer Gene Therapy
- (2016) Jianhua Chen et al. ACS Nano
- Application of conditionally replicating adenoviruses in tumor early diagnosis technology, gene-radiation therapy and chemotherapy
- (2016) Shun Li et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Mesenchymal stem cells deliver and release conditionally replicative adenovirus depending on hepatic differentiation to eliminate hepatocellular carcinoma cells specifically
- (2016) Xiangfei Yuan et al. CANCER LETTERS
- Erratum to: Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model
- (2016) Adel Galal El-Shemi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Adenovirus encoding XAF-1 and TNF-α in the same open reading frame efficiently inhibits hepatocellular cancer cells
- (2016) KAI LI et al. Molecular Medicine Reports
- Immunohistochemical Determination of p53 Protein Overexpression for Predicting p53 Gene Mutations in Hepatocellular Carcinoma: A Meta-Analysis
- (2016) Jiangbo Liu et al. PLoS One
- Image-aided Suicide Gene Therapy Utilizing Multifunctional hTERT-targeting Adenovirus for Clinical Translation in Hepatocellular Carcinoma
- (2016) Yun-Hee Kim et al. Theranostics
- Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA
- (2015) YANG GAO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Polymeric oncolytic adenovirus for cancer gene therapy
- (2015) Joung-Woo Choi et al. JOURNAL OF CONTROLLED RELEASE
- A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma
- (2015) Yigang Wang et al. Oncotarget
- Targeting Gene-Virus-Mediated Manganese Superoxide Dismutase Effectively Suppresses Tumor Growth in Hepatocellular Carcinoma In Vitro and In Vivo
- (2014) Fang Huang et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
- (2014) Shi Jiao et al. CANCER CELL
- VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex
- (2014) Wenjing Zhang et al. CELL RESEARCH
- Key points of basic theories and clinical practice in rAd-p53 (Gendicine™) gene therapy for solid malignant tumors
- (2014) Yi Li et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin
- (2014) Buyun Ma et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- ASPP2 enhances Oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy
- (2014) Ying Shi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Hyaluronan, fluid pressure and stromal resistance in pancreas cancer
- (2013) P P Provenzano et al. BRITISH JOURNAL OF CANCER
- Bone marrow-derived myofibroblasts promote colon tumorigenesis through the IL-6/JAK2/STAT3 pathway
- (2013) Liming Zhu et al. CANCER LETTERS
- Advances in adenovirus-mediated p53 cancer gene therapy
- (2013) Hiroshi Tazawa et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model
- (2013) Wenjia Lou et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- 2-Aminopurine Enhances the Oncolytic Activity of an E1b-Deleted Adenovirus in Hepatocellular Carcinoma Cells
- (2013) David Sharon et al. PLoS One
- Potent antitumor activity of oncolytic adenovirus-mediated SOCS1 for hepatocellular carcinoma
- (2012) L Liu et al. GENE THERAPY
- Overexpression of tumor suppressor TSLC1 by a survivin-regulated oncolytic adenovirus significantly inhibits hepatocellular carcinoma growth
- (2012) Guoqing He et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma
- (2012) Cong-Jun Wang et al. Molecular Cancer
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma
- (2012) JIANG LI et al. ONCOLOGY REPORTS
- Virus chimeras for gene therapy, vaccination, and oncolysis: adenoviruses and beyond
- (2012) Johanna K. Kaufmann et al. TRENDS IN MOLECULAR MEDICINE
- Adenovirus receptors: implications for targeting of viral vectors
- (2012) Niklas Arnberg TRENDS IN PHARMACOLOGICAL SCIENCES
- A novel inhibitor of apoptosis protein (IAP)-interacting protein, Vestigial-like (Vgl)-4, counteracts apoptosis-inhibitory function of IAPs by nuclear sequestration
- (2011) Hyung-Seung Jin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Bioreducible polymer-conjugated oncolytic adenovirus for hepatoma-specific therapy via systemic administration
- (2011) Pyung-Hwan Kim et al. BIOMATERIALS
- Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL
- (2011) X Liu et al. CANCER GENE THERAPY
- Augmenting the Antitumor Effect of TRAIL by SOCS3 with Double-Regulated Replicating Oncolytic Adenovirus in Hepatocellular Carcinoma
- (2011) Rui-Cheng Wei et al. HUMAN GENE THERAPY
- A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma
- (2010) B Sangro et al. CANCER GENE THERAPY
- Oncolytic adenovirus SG600-IL24 selectively kills hepatocellular carcinoma cell lines
- (2010) Xin-Bo Xue WORLD JOURNAL OF GASTROENTEROLOGY
- miR-34a as part of the resistance network in chronic lymphocytic leukemia
- (2008) T. Zenz et al. BLOOD
- MicroRNAs and the Regulation of Vector Tropism
- (2008) Elizabeth J Kelly et al. MOLECULAR THERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now